• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项经过验证的综合评分在预测肝硬化合并自发性细菌性腹膜炎患者短期生存方面显示出优于基于终末期肝病模型(MELD)系统的潜力——一项初步研究。

A Validated Composite Score Demonstrates Potential Superiority to MELD-Based Systems in Predicting Short-Term Survival in Patients with Liver Cirrhosis and Spontaneous Bacterial Peritonitis-A Preliminary Study.

作者信息

Lin Yan-Ting, Chen Wei-Ting, Wu Tsung-Han, Liu Yu, Liu Li-Tong, Teng Wei, Hsieh Yi-Chung, Wu Yen-Mu, Huang Chien-Hao, Hsu Chao-Wei, Chien Rong-Nan

机构信息

Department of Hepatology, Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital, Linkou Medical Center, Taoyuan 33305, Taiwan.

College of Medicine, Chang-Gung University, Taoyuan 33302, Taiwan.

出版信息

Diagnostics (Basel). 2023 Aug 2;13(15):2578. doi: 10.3390/diagnostics13152578.

DOI:10.3390/diagnostics13152578
PMID:37568941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10417459/
Abstract

BACKGROUND

Spontaneous bacterial peritonitis (SBP) is a severe complication in cirrhosis patients with ascites, leading to high mortality rates if not promptly treated. However, specific prediction models for SBP are lacking.

AIMS

This study aimed to compare commonly used cirrhotic prediction models (CTP score, MELD, MELD-Na, iMELD, and MELD 3.0) for short-term mortality prediction and develop a novel model to improve mortality prediction.

METHODS

Patients with the first episode of SBP were included. Prognostic values for mortality were assessed using AUROC analysis. A novel prediction model was developed and validated.

RESULTS

In total, 327 SBP patients were analyzed, with HBV infection as the main etiologies. MELD 3.0 demonstrated the highest AUROC among the traditional models. The novel model, incorporating HRS, exhibited superior predictive accuracy for in-hospital in all patients and 3-month mortality in HBV-cirrhosis, with AUROC values of 0.827 and 0.813 respectively, surpassing 0.8.

CONCLUSIONS

MELD 3.0 score outperformed the CTP score and showed a non-significant improvement compared to other MELD-based scores, while the novel SBP model demonstrated impressive accuracy. Internal validation and an HBV-related cirrhosis subgroup sensitivity analysis supported these findings, highlighting the need for a specific prognostic model for SBP and the importance of preventing HRS development to improve SBP prognosis.

摘要

背景

自发性细菌性腹膜炎(SBP)是肝硬化腹水患者的一种严重并发症,若不及时治疗会导致高死亡率。然而,目前缺乏SBP的特异性预测模型。

目的

本研究旨在比较常用的肝硬化预测模型(CTP评分、MELD、MELD-Na、iMELD和MELD 3.0)对短期死亡率的预测情况,并开发一种新模型以改善死亡率预测。

方法

纳入首次发生SBP的患者。使用受试者工作特征曲线下面积(AUROC)分析评估死亡率的预后价值。开发并验证了一种新的预测模型。

结果

共分析了327例SBP患者,主要病因是乙肝病毒(HBV)感染。在传统模型中,MELD 3.0的AUROC最高。纳入肝肾综合征(HRS)的新模型对所有患者的院内死亡率以及HBV肝硬化患者的3个月死亡率均表现出卓越的预测准确性,AUROC值分别为0.827和0.813,均超过0.8。

结论

MELD 3.0评分优于CTP评分,与其他基于MELD的评分相比有不显著的改善,而新的SBP模型显示出令人印象深刻的准确性。内部验证和HBV相关肝硬化亚组敏感性分析支持了这些发现,凸显了需要针对SBP建立特异性预后模型以及预防HRS发生对改善SBP预后的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f4/10417459/da8e5cb48a10/diagnostics-13-02578-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f4/10417459/8dd7eef3fdde/diagnostics-13-02578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f4/10417459/fccac4df2e90/diagnostics-13-02578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f4/10417459/a24fb8fc3168/diagnostics-13-02578-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f4/10417459/dc3a11f205ba/diagnostics-13-02578-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f4/10417459/da8e5cb48a10/diagnostics-13-02578-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f4/10417459/8dd7eef3fdde/diagnostics-13-02578-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f4/10417459/fccac4df2e90/diagnostics-13-02578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f4/10417459/a24fb8fc3168/diagnostics-13-02578-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f4/10417459/dc3a11f205ba/diagnostics-13-02578-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f4/10417459/da8e5cb48a10/diagnostics-13-02578-g005.jpg

相似文献

1
A Validated Composite Score Demonstrates Potential Superiority to MELD-Based Systems in Predicting Short-Term Survival in Patients with Liver Cirrhosis and Spontaneous Bacterial Peritonitis-A Preliminary Study.一项经过验证的综合评分在预测肝硬化合并自发性细菌性腹膜炎患者短期生存方面显示出优于基于终末期肝病模型(MELD)系统的潜力——一项初步研究。
Diagnostics (Basel). 2023 Aug 2;13(15):2578. doi: 10.3390/diagnostics13152578.
2
Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.终末期肝病模型或许优于其他基于终末期肝病模型的系统,包括 Child-Turcotte-Pugh 评分和白蛋白-胆红素评分,在乙型肝炎病毒相关性肝硬化和自发性细菌性腹膜炎患者中。
Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1256-1263. doi: 10.1097/MEG.0000000000001481.
3
[The predictive value of end-stage liver disease model for spontaneous bacterial peritonitis in cirrhotic patients with ascites].[终末期肝病模型对肝硬化腹水患者自发性细菌性腹膜炎的预测价值]
Zhonghua Nei Ke Za Zhi. 2009 Aug;48(8):629-32.
4
Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.四种基于终末期肝病模型的肝硬化预后系统比较。
Liver Transpl. 2008 Jun;14(6):837-44. doi: 10.1002/lt.21439.
5
Creatinine modified Child-Turcotte-Pugh and integrated model of end-stage liver disease scores as predictors of spontaneous bacterial peritonitis-related in-hospital mortality: Applicable or not.肌酐修正的Child-Turcotte-Pugh评分和终末期肝病积分模型作为自发性细菌性腹膜炎相关住院死亡率预测指标的适用性研究
J Gastroenterol Hepatol. 2015 Jul;30(7):1205-10. doi: 10.1111/jgh.12918.
6
The Usefulness of Mayo End-stage Liver Disease (MELD) and MELD-Sodium (MELD-Na) Scores for Predicting Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis.梅奥终末期肝病(MELD)及MELD-钠(MELD-Na)评分对预测肝硬化自发性细菌性腹膜炎患者死亡率的价值
Cureus. 2023 Apr 30;15(4):e38343. doi: 10.7759/cureus.38343. eCollection 2023 Apr.
7
Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.预测广泛肝病患者的死亡率——对终末期肝病模型(MELD)、Child-Turcotte-Pugh(CTP)评分以及肌酐修正CTP评分的评估
J Clin Exp Hepatol. 2011 Dec;1(3):161-8. doi: 10.1016/S0973-6883(11)60233-8. Epub 2012 Jan 2.
8
Assessment of the Model for End-stage Liver Disease (MELD) Score in Predicting Prognosis of Patients with Alcoholic Hepatitis.终末期肝病模型(MELD)评分对酒精性肝炎患者预后的预测评估
J Clin Exp Hepatol. 2014 Mar;4(1):19-24. doi: 10.1016/j.jceh.2014.02.006. Epub 2014 Feb 27.
9
Model for End-Stage Liver Disease Score Predicts Development of First Episode of Spontaneous Bacterial Peritonitis in Patients With Cirrhosis.终末期肝病模型评分预测肝硬化患者自发性细菌性腹膜炎首发的发生。
Mayo Clin Proc. 2019 Sep;94(9):1799-1806. doi: 10.1016/j.mayocp.2019.02.027. Epub 2019 Aug 7.
10
Prognostic factors associated with in-hospital mortality in patients with spontaneous bacterial peritonitis.自发性细菌性腹膜炎患者住院死亡率相关的预后因素。
Ann Hepatol. 2012 Nov-Dec;11(6):915-20.

引用本文的文献

1
The Development and Appraisal of MELD 3.0 in Liver Diseases: Good Things Never Come Easy.终末期肝病模型(MELD)3.0在肝脏疾病中的发展与评估:好事多磨。
J Clin Transl Hepatol. 2025 Jan 28;13(1):62-68. doi: 10.14218/JCTH.2024.00303. Epub 2024 Nov 12.

本文引用的文献

1
Diagnosis and Management of Cirrhosis and Its Complications: A Review.肝硬化及其并发症的诊断与管理:综述。
JAMA. 2023 May 9;329(18):1589-1602. doi: 10.1001/jama.2023.5997.
2
More immunosuppressive, more immunotherapy responsive? A double-edged sword of HBV-induced immune response in HCC.免疫抑制越强,免疫治疗反应就越好?乙肝病毒诱导的肝癌免疫反应的双刃剑。
Hepatology. 2023 Sep 1;78(3):706-708. doi: 10.1097/HEP.0000000000000393. Epub 2023 Apr 5.
3
MELD 3.0 for adolescent liver transplant candidates.MELD 3.0 用于青少年肝移植候选者。
Hepatology. 2023 Aug 1;78(2):540-546. doi: 10.1097/HEP.0000000000000352. Epub 2023 Mar 22.
4
Bacteremia (Sepsis), Hepatorenal Syndrome, and Serum Creatinine Levels Rather than Types or Microbial Patterns Predicted the Short-Term Survival of Cirrhotic Patients Complicated with Spontaneous Bacterial Peritonitis.菌血症(脓毒症)、肝肾综合征及血清肌酐水平而非类型或微生物模式可预测肝硬化合并自发性细菌性腹膜炎患者的短期生存情况。
Diagnostics (Basel). 2022 Dec 28;13(1):94. doi: 10.3390/diagnostics13010094.
5
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.MELD 3.0:适应新时代的终末期肝病模型。
Gastroenterology. 2021 Dec;161(6):1887-1895.e4. doi: 10.1053/j.gastro.2021.08.050. Epub 2021 Sep 3.
6
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.腹水、自发性细菌性腹膜炎和肝肾综合征的诊断、评估及管理:美国肝病研究协会2021年实践指南
Hepatology. 2021 Aug;74(2):1014-1048. doi: 10.1002/hep.31884.
7
Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis Improve Cirrhosis Outcome Prediction: A Modified Seven-Stage Model as a Clinical Alternative to MELD.肝性脑病和自发性细菌性腹膜炎改善肝硬化预后预测:一种改良的七阶段模型作为终末期肝病模型(MELD)的临床替代方案
J Pers Med. 2020 Oct 22;10(4):186. doi: 10.3390/jpm10040186.
8
Guidelines on the management of ascites in cirrhosis.肝硬化腹水管理指南。
Gut. 2021 Jan;70(1):9-29. doi: 10.1136/gutjnl-2020-321790. Epub 2020 Oct 16.
9
Model for End-Stage Liver Disease-Lactate and Prediction of Inpatient Mortality in Patients With Chronic Liver Disease.终末期肝病模型-乳酸与慢性肝病患者住院死亡率的预测。
Hepatology. 2020 Nov;72(5):1747-1757. doi: 10.1002/hep.31199.
10
Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.终末期肝病模型或许优于其他基于终末期肝病模型的系统,包括 Child-Turcotte-Pugh 评分和白蛋白-胆红素评分,在乙型肝炎病毒相关性肝硬化和自发性细菌性腹膜炎患者中。
Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1256-1263. doi: 10.1097/MEG.0000000000001481.